Braun Stacey Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.6M | Buy |
+246,022
| New | +$28.4M | 0.98% | 37 |
|
|
2024
Q4 | – | Sell |
-218,985
| Closed | -$24.9M | – | 120 |
|
|
2024
Q3 | $24.9M | Sell |
218,985
-7,853
| -3% | -$933K | 0.94% | 38 |
|
|
2024
Q2 | $28.1M | Buy |
226,838
+5,314
| +2% | +$685K | 1.09% | 25 |
|
|
2024
Q1 | $29.2M | Buy |
221,524
+6,402
| +3% | +$789K | 1.16% | 24 |
|
|
2023
Q4 | $23.5M | Sell |
215,122
-5,496
| -2% | -$570K | 1.05% | 32 |
|
|
2023
Q3 | $22.7M | Sell |
220,618
-6,392
| -3% | -$689K | 1.11% | 33 |
|
|
2023
Q2 | $26.2M | Sell |
227,010
-225,656
| -50% | -$25.6M | 1.22% | 20 |
|
|
2023
Q1 | $48.2M | Buy |
452,666
+225,983
| +100% | +$24.4M | 1.26% | 19 |
|
|
2022
Q4 | $25.2M | Buy |
226,683
+11,175
| +5% | +$1.14M | 1.43% | 10 |
|
|
2022
Q3 | $18.6M | Buy |
215,508
+15,663
| +8% | +$1.4M | 1.13% | 25 |
|
|
2022
Q2 | $18.2M | Buy |
199,845
+44,140
| +28% | +$3.91M | 1.04% | 32 |
|
|
2022
Q1 | $12.8M | Sell |
155,705
-15,430
| -9% | -$1.22M | 0.53% | 91 |
|
|
2021
Q4 | $13.1M | Sell |
171,135
-75,419
| -31% | -$6.01M | 0.48% | 92 |
|
|
2021
Q3 | $18.5M | Sell |
246,554
-168
| -0.1% | -$12.8K | 0.74% | 64 |
|
|
2021
Q2 | $19.2M | Sell |
246,722
-10,475
| -4% | -$779K | 0.75% | 67 |
|
|
2021
Q1 | $18.9M | Buy |
257,197
+6,551
| +3% | +$483K | 0.8% | 58 |
|
|
2020
Q4 | $19.6M | Buy |
250,646
+8,364
| +3% | +$640K | 0.88% | 50 |
|
|
2020
Q3 | $19.2M | Sell |
242,282
-1,713
| -0.7% | -$134K | 1.03% | 27 |
|
|
2020
Q2 | $18M | Buy |
243,995
+1,425
| +0.6% | +$107K | 1.04% | 28 |
|
|
2020
Q1 | $17.8M | Sell |
242,570
-21,334
| -8% | -$1.68M | 1.36% | 11 |
|
|
2019
Q4 | $22.9M | Buy |
263,904
+8,504
| +3% | +$698K | 1.27% | 11 |
|
|
2019
Q3 | $20.5M | Buy |
255,400
+2,720
| +1% | +$218K | 1.29% | 12 |
|
|
2019
Q2 | $20.2M | Sell |
252,680
-2,720
| -1% | -$208K | 1.29% | 13 |
|
|
2019
Q1 | $20.3M | Buy |
255,400
+552
| +0.2% | +$41.3K | 1.35% | 10 |
|
|
2018
Q4 | $18.6M | Sell |
254,848
-27,409
| -10% | -$1.93M | 1.47% | 9 |
|
|
2018
Q3 | $19.1M | Sell |
282,257
-8,927
| -3% | -$569K | 1.22% | 19 |
|
|
2018
Q2 | $16.9M | Buy |
291,184
+9,491
| +3% | +$535K | 1.14% | 26 |
|
|
2018
Q1 | $14.6M | Sell |
281,693
-225
| -0.1% | -$12.2K | 1.01% | 45 |
|
|
2017
Q4 | $15.1M | Sell |
281,918
-23,638
| -8% | -$1.31M | 1.01% | 40 |
|
|
2017
Q3 | $18.7M | Sell |
305,556
-25,189
| -8% | -$1.53M | 1.28% | 13 |
|
|
2017
Q2 | $20.2M | Sell |
330,745
-16,092
| -5% | -$980K | 1.31% | 10 |
|
|
2017
Q1 | $21M | Buy |
346,837
+45,971
| +15% | +$2.79M | 1.33% | 9 |
|
|
2016
Q4 | $16.9M | Buy |
300,866
+2,510
| +0.8% | +$147K | 1.11% | 24 |
|
|
2016
Q3 | $17.8M | Buy |
298,356
+205
| +0.1% | +$12K | 1.13% | 26 |
|
|
2016
Q2 | $16.4M | Sell |
298,151
-15,300
| -5% | -$814K | 1.06% | 40 |
|
|
2016
Q1 | $15.8M | Sell |
313,451
-39,900
| -11% | -$1.95M | 1.03% | 46 |
|
|
2015
Q4 | $17.8M | Buy |
353,351
+22,343
| +7% | +$1.13M | 1.12% | 30 |
|
|
2015
Q3 | $15.6M | Sell |
331,008
-53,004
| -14% | -$2.82M | 1.05% | 42 |
|
|
2015
Q2 | $20.9M | Buy |
384,012
+54,714
| +17% | +$3.07M | 0.89% | 37 |
|
|
2015
Q1 | $18.1M | Sell |
329,298
-5,235
| -2% | -$296K | 1.06% | 35 |
|
|
2014
Q4 | $18.1M | Sell |
334,533
-6,314
| -2% | -$352K | 1.1% | 34 |
|
|
2014
Q3 | $19.3M | Sell |
340,847
-10,978
| -3% | -$616K | 1.19% | 18 |
|
|
2014
Q2 | $19.4M | Sell |
351,825
-14,805
| -4% | -$808K | 1.16% | 23 |
|
|
2014
Q1 | $19.9M | Sell |
366,630
-5,094
| -1% | -$264K | 1.16% | 28 |
|
|
2013
Q4 | $17.8M | Sell |
371,724
-3,325
| -0.9% | -$152K | 1.02% | 40 |
|
|
2013
Q3 | $17M | Sell |
375,049
-3,491
| -0.9% | -$159K | 1.05% | 38 |
|
|
2013
Q2 | $16.8M | Buy |
+378,540
| New | +$16.9M | 1.06% | 32 |
|
Other funds holding MRK
VCM
VPM
Braun Stacey Associates's MRK Position: Q1 2026 in Review
Braun Stacey Associates opened a new position in Merck (MRK) in Q1 2026: 246,022 shares worth $29.6M. The stake represents 0.98% of the portfolio and ranks #37 among its holdings. This is a return to the name: Braun Stacey Associates previously reported a position in MRK as recently as Q3 2024.
Braun Stacey Associates first reported a position in MRK in Q2 2013 and has held it in 47 quarters since. The position peaked at $48.2M in Q1 2023. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Braun Stacey Associates held 246,022 shares of Merck worth $29.6M as of Q1 2026.
- Merck was a new Braun Stacey Associates position in Q1 2026.
- Merck made up 0.98% of Braun Stacey Associates's portfolio in Q1 2026, its #37 holding.
- Braun Stacey Associates first reported a position in Merck in Q2 2013 and has held it in 47 quarters since.
- Braun Stacey Associates's Merck position peaked at $48.2M in Q1 2023.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Braun Stacey Associates's 13F filing for Q1 2026, filed 22 Apr 2026.